Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs-Reference-Cited by-同舟云学术

Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs

Published:2024-07-16 Issue: Volume: Page:
ISSN:1573-742X
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Smeets Mark J. R.^ORCID,Kristiansen Eskild Bendix^ORCID,Nemeth Banne^ORCID,Huisman Menno V.^ORCID,Cannegieter Suzanne C.^ORCID,Pedersen Alma Becic^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11239-024-03015-9.pdf

Reference38 articles.

1. Pedersen AB, Andersen IT, Overgaard S et al (2019) Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) group. Acta Orthop 90:298–305. https://doi.org/10.1080/17453674.2019.1611215

2. Forster R, Stewart M (2016) Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Cochrane Database Syst Rev 3:CD004179. https://doi.org/10.1002/14651858.CD004179.pub2

3. Pedersen AB, Mehnert F, Sorensen HT et al (2014) The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement. Bone Jt J 96–B:479–485. https://doi.org/10.1302/0301-620X.96B4.33209

4. Bjørnar̊ BT, Gudmundsen TE, Dahl OE (2006) Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br 88–B:386–391. https://doi.org/10.1302/0301-620X.88B3.17207

5. CRISTAL Study Group (2022) Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL Randomized Trial. JAMA 328:719–727. https://doi.org/10.1001/jama.2022.13416